It targets GLP-1 receptors throughout your gastrointestinal tract, pancreas, and brain
Improve insulin function: GLP-1 increases glucose-dependent insulin release and decreases glucagon secretion, helping stabilize blood sugar [13]
This study did not evaluate any behavioral parameters but did see benefits in some serum markers that are noted to be irregular in patients with ASD
It supports the vascular supply to peripheral tissue at a time when circulation may be a limiting factor
Biosimilars and similar biologics (for injectable GLP-1 analogues such as liraglutide, dulaglutide, and semaglutide) if companies can demonstrate comparability in structure, function, and clinical performance.[11] This framework is what enabled Indias earlier waves of affordable insulin, cancer drugs, and biologics and it is now being replicated for GLP-1 therapies